MedTrace Logo

Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder

NCT07214467 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2025-10-28

No results posted yet for this study

Summary

The purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.

Conditions

  • Substance Use Disorder (SUD)
  • Opioid Use Disorder (OUD)

Interventions

DEVICE

Deep Brain Stimulation

An individualized aDBS protocol will be used to examine therapeutic effect.

Sponsors & Collaborators

Principal Investigators

  • Khaled Moussawi, MD, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-24
Primary Completion
2031-11-22
Completion
2031-11-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07214467 on ClinicalTrials.gov